Wenkan Zhang

750 total citations
27 papers, 465 citations indexed

About

Wenkan Zhang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Wenkan Zhang has authored 27 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Wenkan Zhang's work include Bone health and treatments (5 papers), Autophagy in Disease and Therapy (4 papers) and Immune cells in cancer (4 papers). Wenkan Zhang is often cited by papers focused on Bone health and treatments (5 papers), Autophagy in Disease and Therapy (4 papers) and Immune cells in cancer (4 papers). Wenkan Zhang collaborates with scholars based in China and Ukraine. Wenkan Zhang's co-authors include Weiqi Yan, Jiahong Meng, Zhaoming Ye, Eloy Yinwang, Yiying Qi, Haochen Mou, Binghao Li, Guangyao Jiang, Xupeng Chai and Guoqi Li and has published in prestigious journals such as Advanced Materials, Nature Communications and The FASEB Journal.

In The Last Decade

Wenkan Zhang

26 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenkan Zhang China 14 221 120 95 83 53 27 465
Shuting Yang United States 15 373 1.7× 106 0.9× 49 0.5× 95 1.1× 40 0.8× 40 605
Mohamed Essameldin Abdelgawad Egypt 11 235 1.1× 144 1.2× 94 1.0× 40 0.5× 19 0.4× 15 488
Feiwu Kang China 9 280 1.3× 126 1.1× 60 0.6× 137 1.7× 25 0.5× 27 499
Nicole Stuendl Austria 15 223 1.0× 108 0.9× 35 0.4× 88 1.1× 93 1.8× 17 456
Chengyu Lv China 12 162 0.7× 101 0.8× 54 0.6× 62 0.7× 38 0.7× 28 382
Yeon-Suk Yang United States 12 317 1.4× 80 0.7× 40 0.4× 78 0.9× 30 0.6× 18 511
Yaqing Yang China 8 250 1.1× 58 0.5× 119 1.3× 40 0.5× 22 0.4× 13 472
Carlos Resende Portugal 12 258 1.2× 85 0.7× 59 0.6× 129 1.6× 71 1.3× 25 559

Countries citing papers authored by Wenkan Zhang

Since Specialization
Citations

This map shows the geographic impact of Wenkan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenkan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenkan Zhang more than expected).

Fields of papers citing papers by Wenkan Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenkan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenkan Zhang. The network helps show where Wenkan Zhang may publish in the future.

Co-authorship network of co-authors of Wenkan Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenkan Zhang. A scholar is included among the top collaborators of Wenkan Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenkan Zhang. Wenkan Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wenkan, Hao Zhou, Eloy Yinwang, et al.. (2025). Bacteriophage immunotherapy with artificial antigen-directed immune labeling against bacterial infection. Science Advances. 11(35). eadr1911–eadr1911.
2.
Zhou, Hao, Wenkan Zhang, Hengyuan Li, et al.. (2024). Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunity. Science Advances. 10(3). eadi4298–eadi4298. 20 indexed citations
3.
Zhang, Wenkan, Hao Zhou, Tao Chen, et al.. (2024). The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy. Cancer and Metastasis Reviews. 43(4). 1419–1443. 11 indexed citations
4.
Chen, Shixin, Haochen Mou, Wenkan Zhang, et al.. (2024). Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors. Frontiers in Immunology. 15. 1335366–1335366. 15 indexed citations
5.
Chen, Liang, Zhenxuan Shao, Zengjie Zhang, et al.. (2023). An On‐Demand Collaborative Innate–Adaptive Immune Response to Infection Treatment. Advanced Materials. 36(15). e2304774–e2304774. 25 indexed citations
6.
Zhang, Wenkan, Hao Zhou, Hengyuan Li, et al.. (2023). Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondria. Cell Reports. 42(9). 113147–113147. 31 indexed citations
7.
Mou, Haochen, Hao Qu, Binghao Li, et al.. (2022). Can “domino” therapy effectively treat the infection around the prosthesis after the limb salvage surgery of bone tumor? - A study of sequential therapy. International Journal of Surgery. 101. 106630–106630. 1 indexed citations
8.
Li, Binghao, Shan Li, Wenlong Lin, et al.. (2022). Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion. Nature Communications. 13(1). 6308–6308. 69 indexed citations
9.
Zhang, Wenkan, Guangyao Jiang, Xiaozhong Zhou, et al.. (2022). α-Mangostin inhibits LPS-induced bone resorption by restricting osteoclastogenesis via NF-κB and MAPK signaling. Chinese Medicine. 17(1). 34–34. 14 indexed citations
10.
He, Bin, et al.. (2021). Fraxinellone Has Anticancer Activity by Inducing Osteosarcoma Cell Apoptosis via Promoting Excessive Autophagy Flux. Frontiers in Pharmacology. 12. 653212–653212. 9 indexed citations
11.
Mou, Haochen, Zhan Wang, Wenkan Zhang, et al.. (2021). Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis Surgeries. Frontiers in Oncology. 11. 693689–693689. 7 indexed citations
12.
Zhang, Yongxing, Yang Chen, Hangxiang Sun, et al.. (2021). SENP3-Mediated PPARγ2 DeSUMOylation in BM-MSCs Potentiates Glucocorticoid-Induced Osteoporosis by Promoting Adipogenesis and Weakening Osteogenesis. Frontiers in Cell and Developmental Biology. 9. 693079–693079. 10 indexed citations
13.
Li, Guoqi, Yikai Wang, Hao Zhou, et al.. (2021). Application of Immune Infiltration Signature and Machine Learning Model in the Differential Diagnosis and Prognosis of Bone-Related Malignancies. Frontiers in Cell and Developmental Biology. 9. 630355–630355. 20 indexed citations
15.
Chai, Xupeng, Eloy Yinwang, Zenan Wang, et al.. (2021). Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value. Frontiers in Oncology. 11. 692788–692788. 24 indexed citations
16.
17.
Zhang, Wenkan, Jiahong Meng, Yiying Qi, et al.. (2020). Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody. Biomedicine & Pharmacotherapy. 131. 110541–110541. 15 indexed citations
18.
Meng, Jiahong, Wenkan Zhang, Cong Wang, et al.. (2019). Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity. Biochemical Pharmacology. 171. 113715–113715. 56 indexed citations
19.
Meng, Jiahong, Chenhe Zhou, Wenkan Zhang, et al.. (2019). Stachydrine prevents LPS‐induced bone loss by inhibiting osteoclastogenesis via NF‐κB and Akt signalling. Journal of Cellular and Molecular Medicine. 23(10). 6730–6743. 33 indexed citations
20.
Zhang, Wenkan, et al.. (2019). <p>Water Extract of Sporoderm-Broken Spores of <em>Ganoderma lucidum</em> Induces Osteosarcoma Apoptosis and Restricts Autophagic Flux</p>. OncoTargets and Therapy. Volume 12. 11651–11665. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026